Zydus Cadila to commence phase II clinical trials of Covid-19 vaccine from August 6
Published
Published
Novavax Inc (NASDAQ:NVAX) is reportedly expecting to submit its COVID-19 vaccine candidate before US authorities in December. Chief..
The apex health research body, ICMR, is in the process of developing a vaccine portal which will provide information related to the..